Acquired by Orthofix Medical Inc. in Jan 2023
SPNE - SeaSpine Holdings Corporation
NASDAQ
->
Healthcare
->
Medical Devices
Carlsbad,
United States
Type: Equity
SPNE price evolution
SPNE
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $46.76 | $66.08 | $81.44 | $83.11 |
| Short term investments | ||||
| Net receivables | $43.54 | $34.44 | $36.07 | $36.23 |
| Inventory | $83.99 | $85.91 | $76.53 | $72.3 |
| Total current assets | $174.87 | $190 | $198.04 | $195.96 |
| Long term investments | ||||
| Property, plant & equipment | $72.71 | $71.45 | $56.94 | $53.84 |
| Goodwill & intangible assets | $121.13 | $122.97 | $124.81 | $126.65 |
| Total noncurrent assets | $199.26 | $195.57 | $182.37 | $181.3 |
| Total investments | ||||
| Total assets | $374.12 | $385.57 | $380.41 | $377.27 |
| Current liabilities | ||||
| Accounts payable | $17.78 | $19.22 | $16.48 | $20.3 |
| Deferred revenue | $2.14 | $2.26 | $2.37 | $1.54 |
| Short long term debt | $2.41 | $2.38 | $27.23 | $2.23 |
| Total current liabilities | $55.05 | $54.44 | $72.95 | $52.98 |
| Long term debt | $40.94 | $40.53 | $5.4 | $5.87 |
| Total noncurrent liabilities | $44.62 | $44.3 | $10.64 | $11.92 |
| Total debt | $43.35 | $42.91 | $32.63 | $8.1 |
| Total liabilities | $99.67 | $98.74 | $83.59 | $64.9 |
| Shareholders' equity | ||||
| Retained earnings | -$319.65 | -$304.15 | -$290.21 | -$273.6 |
| Other shareholder equity | $0.43 | $0.93 | $1.4 | $1.57 |
| Total shareholder equity | $274.46 | $286.83 | $296.82 | $312.36 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $83.11 | $76.81 | $20.2 | $24.23 |
| Short term investments | $29.8 | |||
| Net receivables | $36.23 | $26.15 | $24.9 | $20.34 |
| Inventory | $72.3 | $54.04 | $47.16 | $42.74 |
| Total current assets | $195.96 | $160.89 | $96.16 | $120.06 |
| Long term investments | ||||
| Property, plant & equipment | $53.84 | $39.08 | $25.75 | $22.62 |
| Goodwill & intangible assets | $126.65 | $13.88 | $19.17 | $28.71 |
| Total noncurrent assets | $181.3 | $53.51 | $45.56 | $52.28 |
| Total investments | $29.8 | |||
| Total assets | $377.27 | $214.4 | $141.72 | $172.34 |
| Current liabilities | ||||
| Accounts payable | $20.3 | $5.01 | $7.45 | $9.21 |
| Deferred revenue | $1.54 | |||
| Short long term debt | $2.23 | $3.26 | ||
| Total current liabilities | $52.98 | $30.73 | $30.48 | $26.55 |
| Long term debt | $5.87 | $11.86 | ||
| Total noncurrent liabilities | $11.92 | $11.96 | $1.48 | $3.71 |
| Total debt | $8.1 | $15.12 | ||
| Total liabilities | $64.9 | $42.68 | $31.96 | $30.26 |
| Shareholders' equity | ||||
| Retained earnings | -$273.6 | -$219.26 | -$176.08 | -$136.8 |
| Other shareholder equity | $1.57 | $2.12 | $1.43 | $1.6 |
| Total shareholder equity | $312.36 | $171.72 | $109.76 | $142.09 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $67.15 | $56.32 | $50.69 | $55.59 |
| Cost of revenue | $26.64 | $19.13 | $20.38 | $25.73 |
| Gross Profit | $40.51 | $37.19 | $30.32 | $29.86 |
| Operating activities | ||||
| Research & development | $6.6 | $5.65 | $5.85 | $6.39 |
| Selling, general & administrative | $47.75 | $45.22 | $40.45 | $41.77 |
| Total operating expenses | $55.2 | $51.73 | $47.15 | $48.9 |
| Operating income | -$14.69 | -$14.54 | -$16.83 | -$19.04 |
| Income from continuing operations | ||||
| EBIT | -$15.11 | -$15.09 | -$16.83 | -$19.2 |
| Income tax expense | $0.39 | -$1.15 | -$0.23 | -$0.41 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$15.5 | -$13.95 | -$16.6 | -$18.79 |
| Income (for common shares) | -$15.5 | -$13.95 | -$16.6 | -$18.79 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $191.45 | $154.34 | $159.08 | $143.44 |
| Cost of revenue | $76.86 | $56.84 | $57.98 | $55.97 |
| Gross Profit | $114.59 | $97.5 | $101.1 | $87.47 |
| Operating activities | ||||
| Research & development | $22.01 | $16.26 | $15.13 | $12.06 |
| Selling, general & administrative | $150.24 | $120.18 | $117.04 | $105.39 |
| Total operating expenses | $175.56 | $140.93 | $140.33 | $120.61 |
| Operating income | -$60.98 | -$43.43 | -$39.22 | -$33.14 |
| Income from continuing operations | ||||
| EBIT | -$55.45 | -$42.96 | -$38.92 | -$33.4 |
| Income tax expense | -$1.1 | $0.22 | $0.36 | $0.13 |
| Interest expense | ||||
| Net income | ||||
| Net income | -$54.35 | -$43.18 | -$39.28 | -$33.52 |
| Income (for common shares) | -$54.35 | -$43.18 | -$39.28 | -$33.52 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$15.5 | -$13.95 | -$16.6 | -$18.79 |
| Operating activities | ||||
| Depreciation | $4.34 | $4.29 | $4.2 | $3.65 |
| Business acquisitions & disposals | $0.33 | |||
| Stock-based compensation | $3.65 | $3.7 | $2.82 | $3.06 |
| Total cash flows from operations | -$11.07 | -$8.13 | -$14.99 | -$11.13 |
| Investing activities | ||||
| Capital expenditures | -$7.94 | -$7.74 | -$10.06 | -$9.35 |
| Investments | ||||
| Total cash flows from investing | -$7.94 | -$7.74 | -$10.06 | -$8.97 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.03 | $0.72 | -$1.58 | $0.87 |
| Net borrowings | $25 | |||
| Total cash flows from financing | -$0.04 | $0.71 | $23.4 | $0.86 |
| Effect of exchange rate | -$0.26 | -$0.2 | -$0.02 | -$0.08 |
| Change in cash and equivalents | -$19.32 | -$15.36 | -$1.67 | -$19.33 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$54.35 | -$43.18 | -$39.28 | -$33.52 |
| Operating activities | ||||
| Depreciation | $13.93 | $10.72 | $10.35 | $10.7 |
| Business acquisitions & disposals | -$28 | |||
| Stock-based compensation | $11.86 | $10.36 | $7.81 | $5.8 |
| Total cash flows from operations | -$33.51 | -$24.6 | -$20.28 | -$12.56 |
| Investing activities | ||||
| Capital expenditures | -$27.4 | -$17.04 | -$12.83 | -$8.35 |
| Investments | -$0.01 | $30 | -$29.76 | |
| Total cash flows from investing | -$55.36 | -$17.04 | $17.17 | -$38.1 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $95.64 | $92.09 | -$0.69 | $64.5 |
| Net borrowings | -$0.04 | $6.17 | -$0.17 | |
| Total cash flows from financing | $95.55 | $98.14 | -$0.83 | $64.2 |
| Effect of exchange rate | -$0.38 | $0.12 | -$0.09 | -$0.09 |
| Change in cash and equivalents | $6.29 | $56.61 | -$4.03 | $13.45 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 37.20M |
| Revenue | $229.75M |
|---|---|
| EBITDA | -$49.74M |
| EBIT | -$66.23M |
| Net Income | -$64.84M |
| Revenue Q/Q | 44.57% |
| Revenue Y/Y | 26.03% |
| P/E ratio | 0.00 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.00 |
| Book/Share | 7.37 |
| Cash/Share | 1.26 |
| EPS | -$1.74 |
|---|---|
| ROA | -17.09% |
| ROE | -22.16% |
| Debt/Equity | 0.21 |
|---|---|
| Net debt/EBITDA | -1.06 |
| Current ratio | 3.18 |
| Quick ratio | 1.65 |